Meitheal Pharmaceuticals, Inc recalls
Every recall we track for Meitheal Pharmaceuticals, Inc — 3 in all, from 2021–2026 — plus the complaints and injury reports the public filed about them.
Recalls per year, by danger level
3 recalls since 2017.
All FDA recall records for Meitheal Pharmaceuticals, Inc since 2017, counted by recall date (one bar per calendar year; 2026 is partial). Danger level is GovInfoNow’s plain-language rating; “not yet rated” records are still being written up.
| Year | Stop using now | Use caution | Lower risk | Not yet rated | Total |
|---|---|---|---|---|---|
| 2017 | 0 | 0 | 0 | 0 | 0 |
| 2018 | 0 | 0 | 0 | 0 | 0 |
| 2019 | 0 | 0 | 0 | 0 | 0 |
| 2020 | 0 | 0 | 0 | 0 | 0 |
| 2021 | 0 | 0 | 1 | 1 | 2 |
| 2022 | 0 | 0 | 0 | 0 | 0 |
| 2023 | 0 | 0 | 0 | 0 | 0 |
| 2024 | 0 | 0 | 0 | 0 | 0 |
| 2025 | 0 | 0 | 0 | 0 | 0 |
| 2026 (to date) | 0 | 1 | 0 | 0 | 1 |
What to do if you have a recalled Meitheal Pharmaceuticals, Inc product
- Match the NDC and lot number on your bottle or box to the recall.
- Don’t stop a prescription on your own — ask your pharmacist or doctor for a replacement first.
- Report side effects to FDA MedWatch.
All Meitheal Pharmaceuticals, Inc recalls
3 shown- Use cautionDrug
Meitheal Pharmaceuticals, Inc recalls Cetrorelix Acetate for Injection (Kit), 0.25 mg per vial, Single-Dose Kit, Rx Only, Mfd. for: Meitheal Pharmaceuticals,
Meitheal Pharmaceuticals recalls Cetrorelix Acetate injection kits with missing or duplicated needles. This could cause injection errors. Return the kit to the pharmacy for a replacement.
Meitheal PharmaceuticalsFeb 9, 2026 - UnratedDrug
Meitheal Pharmaceuticals Inc recalls Glycopyrrolate Injection, USP 4mg per 20mL, 20 mL Multi-Dose Vials, Rx only, Mfd for Meitheal Pharmaceuticals, Chicago,
Meitheal Pharmaceuticals recalls 4mg per 20mL Glycopyrrolate Injection vials due to failed impurities and degradation. Affected lots expire Dec 2021-Apr 2022. Consumers should contact for details.
Meitheal PharmaceuticalsSep 3, 2021 - Lower riskDrug
Meitheal Pharmaceuticals Inc recalls Cisatracurium Besylate Injection, USP, 10mg per 5mL (2 mg per mL), Single-Dose Vial (NDC 71288-712-05), packaged as 10
Meitheal Pharmaceuticals recalls 10-vial Cisatracurium Besylate Injection due to mislabeling with Phenylephrine Hydrochloride. Affected units may contain incorrect medication.
Meitheal PharmaceuticalsJan 27, 2021
Meitheal Pharmaceuticals, Inc recall questions
How many recalls has Meitheal Pharmaceuticals, Inc had?
3 recalls from Meitheal Pharmaceuticals, Inc are on record with U.S. safety agencies, from 2021–2026.
What is the most recent Meitheal Pharmaceuticals, Inc recall?
Meitheal Pharmaceuticals, Inc recalls Cetrorelix Acetate for Injection (Kit), 0.25 mg per vial, Single-Dose Kit, Rx Only, Mfd. for: Meitheal Pharmaceuticals,, dated Feb 9, 2026. Every Meitheal Pharmaceuticals, Inc recall is listed on this page, newest first.
What should I do if I have a recalled Meitheal Pharmaceuticals, Inc product?
Match the NDC and lot number on your bottle or box to the recall. Don’t stop a prescription on your own — ask your pharmacist or doctor for a replacement first. Report side effects to FDA MedWatch.
How do I get alerts for new Meitheal Pharmaceuticals, Inc recalls?
Sign up for free email alerts on GovInfoNow — we check official CPSC, FDA, USDA and NHTSA data every day and email you only when a recall matches what you follow.